User banner image
User avatar
  • admin

Posts

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics...

4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical...

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously signed binding Term Sheet between Vincerx,...

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement COPENHAGEN, Denmark; February 28, 2025 – Genmab A/S (Nasdaq: GMAB) – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse...

AVIDLOVE Partners with AngiWings: A Captivating Fusion of Sensuality, Empowerment, and High-Fashion Elegance

New York, NY, Feb. 28, 2025 (GLOBE NEWSWIRE) — As the global fashion scene turns its eyes to Milan Fashion Week and Paris Fashion Week, AVIDLOVE ...

Supermicro Expands US Manufacturing Capacity and Development of Industry-Leading Total IT Solutions with Third Campus in Silicon Valley

Supermicro Drives Innovation, Job Creation, and Economic Growth in San Jose‘s Thriving Tech Market SAN JOSE, Calif., March 1, 2025 /PRNewswire/ — Supermicro, Inc. (NASDAQ: SMCI),...

AIIB Report Urges Infrastructure Development to Prioritize Health, Climate and Nature to Save Lives and Protect Planet

CAPE TOWN, South Africa, March 1, 2025 /PRNewswire/ — Amid accelerating climate change and an increasingly challenged global health system, a new report from the Asian...

MAIRE AND KAZAKH-BRITISH TECHNICAL UNIVERSITY SIGN MEMORANDUM ON THE DEVELOPMENT OF INTERNATIONAL COOPERATION IN SCIENCE AND EDUCATION TO FOSTER COMPETENCES FOR THE ENERGY TRANSITION

MILAN, March 1, 2025 /PRNewswire/ — MAIRE has signed a Memorandum of Understanding with Kazakh-British Technical University (KBTU) to cooperate on further enhancing international collaboration...

QMMM Holdings Limited Announces to receive Nasdaq Minimum Bid Price Deficiency Letter

HONG KONG, Feb. 28, 2025 /PRNewswire/ — QMMM Holdings Limited (Nasdaq: QMMM) (the “Company” or “QMMM Holdings”), a digital media advertising, virtual avatar & virtual...

Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases

Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopic dermatitis Interim safety and pharmacokinetic...